Brief: Bellicum Pharmaceuticals Says Entered Into First Amendment To Loan & Security Agreement
31/12/2019 22:29
Dec 31 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS INC - ON DEC 24, 2019, CO ENTERED
INTO
A FIRST AMENDMENT TO LOAN & SECURITY AGREEMENT
* BELLICUM PHARMACEUTICALS - LOAN AGREEMENT AMENDED TO
PROVIDE FOR
CO'S CONSUMMATION OF ASSET SALE, PROVIDED SALE OCCURS ON OR
PRIOR TO MARCH 31, 2020
* BELLICUM PHARMACEUTICALS - LOAN AGREEMENT AMENDED TO
EXTEND
INTEREST-ONLY PERIOD BY UP TO 18 MONTHS IF ASSET SALE OCCURS ON
OR PRIOR TO MAR 31, 2020
Source: (https://bit.ly/2F6kVwt)
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview